Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
• AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Cancer
• New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
• Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer
• Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation
• Avastin(R) Gives an Additional 4 Months of Life to Patients With one of the Most Common Types of Lung Cancer
• New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
• New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
• Tarceva(R) Delivers Benefits Across Broad Range of NSCLC Patients - Confirmed by New Data
• Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer

Presseportal: Roche Pharmaceuticals

Behandlung mit PEGASYS(R) plus COPEGUS(R) verbessert die Heilungs of CHMP Opinion on Tarceva in Pancreatic Cancer at the European Medicines Agency

Bankkaufmann - News

Tarceva(R) Delivers Benefits Across Broad Range of NSCLC Patients Patients With Pancreatic Cancer can Benefit From Avastin(R) Plus Tarceva(R) 31.05.2008

EXAMINE THE BIOMARKERS: THE EXPANDING GLOBAL MARKET

AVASTIN.TARCEVA.NEXAVAR.ERBITUX.EXELIXIS' XL880.AVALON'S AVN944.SUPERGEN'S MP470 TABLE 53 POTENTIAL BENEFITS EXPECTED FROM CANCER BIOMARKERS

GENENTECH AND OSI PHARMACEUTICALS ANNOUNCE TOPLINE RESULTS FROM PHASE ...

from Phase III Study Evaluating the Combination of Avastin and Tarceva as in patients with pancreatic cancer receiving Tarceva plus gemcitabine were

Patients With Pancreatic Cancer can Benefit From Avastin(R) Plus ...

Patients With Pancreatic Cancer can Benefit From Avastin(R) Plus Tarceva(R) Tarceva in This Difficult-to-Treat Disease - ABSTRACT No: 4507 Adding Avastin